Analyst Downgrades Aravive: Grapples With Trial Setback, Strategic Alternatives

Monday, Aravive Inc (NASDAQ: ARAV) filed its quarterly 10Q for the quarter ended 30 June with the SEC. To preserve cash, the company terminated Phase 1b/P2 trials of batiraxcept in Clear Cell Renal Cell Carcinoma (ccRCC) and pancreatic adenocarcinoma. It will not continue either the ccRCC or the pancreatic adenocarcinoma programs unless it raises additional capital.  Earlier this month, […]

Looking Into MetLife’s Recent Short Interest

MetLife’s (NYSE:MET) short percent of float has fallen 6.92% since its last report. The company recently reported that it has 9.31 million shares sold short, which is 1.48% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.78 days to cover their short positions on average. […]

Peering Into Constellation Energy’s Recent Short Interest

Constellation Energy’s (NYSE:CEG) short percent of float has fallen 6.43% since its last report. The company recently reported that it has 6.60 million shares sold short, which is 2.33% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.89 days to cover their short positions on […]

(MS) – Analyzing Morgan Stanley’s Short Interest

Morgan Stanley’s (NYSE:MS) short percent of float has risen 12.5% since its last report. The company recently reported that it has 18.34 million shares sold short, which is 1.44% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.04 days to cover their short positions on […]